ENTRY       D09539                      Drug
NAME        Gabapentin enacarbil (JAN/USAN/INN);
            Horizant (TN)
PRODUCT     HORIZANT (Azurity Pharmaceuticals)
FORMULA     C16H27NO6
EXACT_MASS  329.1838
MOL_WEIGHT  329.3887
CLASS       Neuropsychiatric agent
             DG01574  Calcium channel alpha-2 delta blocker
             DG03199  Antiepileptic agent
              DG02037  GABA mimetic antiepileptic
REMARK      Therapeutic category: 1190
            ATC code: N02BF01
            Chemical structure group: DG01245
            Product (DG01245): D00332<JP/US> D09539<JP/US>
EFFICACY    Anticonvulsant
  DISEASE   Restless legs syndrome [DS:H01597]
            Postherpetic neuralgia [DS:H01624]
COMMENT     Active form of prodrug: Gabapentin [DR:D00332]
TARGET      CACNA2D [HSA:781 9254 55799 93589] [KO:K04858 K04859 K04860 K04861]
            SLC6A1 (GAT1) [HSA:6529] [KO:K05034]
  PATHWAY   hsa04010(55799+781+9254+93589)  MAPK signaling pathway
            hsa04727(6529)  GABAergic synapse
INTERACTION  
STR_MAP     map07033  Anticonvulsants
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N02 ANALGESICS
               N02B OTHER ANALGESICS AND ANTIPYRETICS
                N02BF Gabapentinoids
                 N02BF01 Gabapentin
                  D09539  Gabapentin enacarbil (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Gamma-aminobutyric Acid (GABA) Augmenting Agents
               GABA Agents, Other
                Gabapentin
                 D09539  Gabapentin enacarbil (JAN/USAN/INN)
             Central Nervous System Agents
              Central Nervous System, Other
               Gabapentin
                D09539  Gabapentin enacarbil (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D09539  Gabapentin enacarbil (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01574  Calcium channel alpha-2 delta blocker
               DG01245  Gabapentin
                D09539  Gabapentin enacarbil
              DG03199  Antiepileptic agent
               DG02037  GABA mimetic antiepileptic
                DG01245  Gabapentin
                 D09539  Gabapentin enacarbil
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D09539  Gabapentin enacarbil
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA2D
                 D09539  Gabapentin enacarbil (JAN/USAN/INN) &lt;JP/US&gt;
             Transporters
              Solute carrier family
               SLC6
                SLC6A1 (GAT1)
                 D09539  Gabapentin enacarbil (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09539
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09539
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09539
            Prodrugs [br08324.html]
             D09539
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01574  Calcium channel alpha-2 delta blocker
               DG01245  Gabapentin
              DG03199  Antiepileptic agent
               DG02037  GABA mimetic antiepileptic
                DG01245  Gabapentin
DBLINKS     PubChem: 96026219
            LigandBox: D09539
ATOM        23
            1   C1x C    17.3600  -19.4600
            2   C1x C    17.3600  -20.8600
            3   C1z C    18.5500  -21.5600
            4   C1x C    19.8100  -20.8600
            5   C1x C    19.8100  -19.4600
            6   C1x C    18.5500  -18.7600
            7   N1b N    16.1700  -21.5600
            8   C1b C    17.3600  -22.2600
            9   C1b C    19.7400  -22.2600
            10  C6a C    20.9300  -21.5600
            11  O6a O    20.9300  -20.1600
            12  O6a O    22.1453  -22.2551
            13  C7a C    14.9576  -22.2600
            14  O7a O    13.7451  -21.5600
            15  C1c C    12.5327  -22.2600
            16  O7a O    11.3203  -21.5600
            17  C7a C    10.1078  -22.2600
            18  C1c C     8.8954  -21.5600
            19  C1a C     7.6830  -22.2600
            20  O6a O    14.9576  -23.6598
            21  C1a C    12.5327  -23.6600
            22  O6a O    10.1078  -23.6597
            23  C1a C     8.8954  -20.1600
BOND        23
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     7   8 1
            8     8   3 1
            9     3   9 1
            10    9  10 1
            11   10  11 2
            12   10  12 1
            13    7  13 1
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18   17  18 1
            19   18  19 1
            20   13  20 2
            21   15  21 1
            22   17  22 2
            23   18  23 1
///
